HEART LIGHT...A NATION WIDE NEW TRIAL AT BEAUMONT OFFERS HOPE TO THOSE THAT SUFFER FROM ATRIAL FIBRILLATION!

EKG of Atrial Fibrillation

Heart Light is an exciting National Research Trial using new technology to treat Paroxysmal Atrial Fibrillation.  William Beaumont Hospital is one of only 22 centers in the United States to offer this trial also one of the highest for enrollment.   Michigan Heart Group's own Dr. Kutinsky is the principle investigator at Beaumont.

The technology is called Cardio Focus, an endoscopic laser balloon system used to isolate the pulmonary veins and cure Paroxysmal Atrial Fibrillation.  The technology is cutting edge for many reasons, first the operator can visualize how and where the treatment is being directed and second it has increased efficacy and success for curing Atrial Fibrillation.  If you want more information or are interested in seeing if you are eligible for the trial, please visit, www.cardiofocus.com.  The deadline for applications is October 1st.